BPC-157 + TB-500 Blend · 20 mg
Published- batch · LOT
- B-2026-BPC157-TB500-20-001
- Laboratory
- Janoshik
- purity
- 99.99%
- Test date
- 28.07.2026
Analytics cookies help us understand what works in the catalog. Accept all, reject non-essential ones, or choose categories below. Privacy policy
Selected size: 20 mg
20 mg analysis published
Research, properties and limitations
AI can make mistakes
Titration schedule · reference
The information below is provided from public sources for reference only. It is not advice or instructions for use; products are intended for laboratory research only and not for human consumption.
| Period / condition | Dose | Escalation |
|---|---|---|
| Loading phase (weeks 1-4) | BPC-157 250-500 mcg/day SubQ + TB-500 2-2.5 mg twice weekly | Starting dose |
| Maintenance phase (weeks 5-8) | BPC-157 250 mcg/day + TB-500 2 mg weekly | Maximum in this schedule |
| Course length | 4-8 weeks (up to 12 for chronic cases) | , |
Research overview · reference
Below is a short summary of what the authors of published studies reported. It is not medical advice or instructions for use; products are intended for laboratory research only and not for human consumption.
| Effect | Model or participants | How often or as described | Source |
|---|---|---|---|
| Adverse events of the BPC-157 + TB-500 blend itself | No study of this blend among the cited sources | Reaction frequencies for the blend cannot be estimated: none of the sources tested the mixture | [1–3] |
| Mild or moderate events without serious events (intact thymosin β4, not the blend) | Healthy volunteers, intravenous intact thymosin β4 | Described qualitatively; no serious events; intact β4 findings do not transfer to the blend or an unidentified fragment | [2] |
| Clinical adverse reactions in the wound-repair study | Rodents, thymosin β4 and synthetic LKKTETQ fragment |
FAQ
Find answers to questions about BPC-157 + TB-500 Blend and related materials.
It is a ready combination of the two best-known recovery peptides in one vial. They are paired because their mechanisms differ and complement each other: BPC-157 supports new vessel growth and cell migration near the damage, while TB-500 manages the actin skeleton of cells throughout the body.
Source / documentationBecause of the difference in action: in protocols, BPC-157 is often placed closer to the area of interest, while TB-500 acts systemically — its injection site does not matter. In the blend, both go in with a single injection, without two separate vials and two solutions.
Source / documentationHonestly: the fixed combination is not clinically validated. It is a convenient form of two separately studied peptides, not a separately researched drug; controlled data on the mixture itself is scarce. The pairing logic and the component data are in the BPC-157 and TB-500 monographs in our wiki.
Source / documentationThe powder is dissolved with bacteriostatic water and injected under the skin in a single injection. Schedules for the mixture specifically are in the blend dosing guide on this page; for the individual components, see their own pages.
Source / documentationThe difference is flexibility versus convenience. Separate vials let you dose each peptide independently; the blend means one injection and a fixed proportion. An expanded version of the same idea is the four-component KLOW blend.
Source / documentationKeep the dry powder in a dry, dark place at a low temperature; once dissolved, store it in the refrigerator and do not freeze it again. Details are in the blend guide on this page.
Source / documentationYou can buy the blend right on this page of our store; current prices and stock are shown in the product card. We deliver across Ukraine with Nova Poshta — to a branch, a parcel locker, or by courier. Payment is by card, by crypto (with a 5% discount), or on delivery. Every vial ships with the certificate of analysis (COA) for its exact batch.
Source / documentationCertificates shown: 1
| Clinical adverse reactions were not studied — the study examined wound repair |
| [3] |
Share your experience
No reviews yet. Tell others what you think of this product.
This is a ready combination of the two best-known recovery peptides in one vial: BPC-157 and TB-500. They are paired because their mechanisms differ and complement each other: BPC-157 supports new vessel growth and cell migration near the damage, while TB-500 manages the actin skeleton of cells throughout the body.
A practical difference worth knowing: in protocols, BPC-157 is often placed closer to the area of interest, while TB-500 acts systemically — its injection site does not matter. In the blend, both go in with a single injection.
Honestly about the limits: the fixed combination is not clinically validated — it is a convenient form of two separately studied peptides, not a separately researched drug. Controlled data on the mixture itself is scarce; the pairing logic and the component data are in the BPC-157 and TB-500 monographs.
How it is used: the dry powder is dissolved with bacteriostatic water and injected under the skin. Schedules for the mixture specifically are in the blend dosing guide; the full line is in the healing and regeneration category. An expanded version of the same idea is the four-component blend KLOW.
Every batch is purity-tested by HPLC, and the certificate of analysis (COA) for your exact batch is in our COA archive. Keep the dry powder in a dry, dark place at a low temperature, and the dissolved solution in the refrigerator.
Buy 2, get the 3rd free
The set contains two vials of 20 mg.
40 mg: Best value · Save ≈ $13.48